Sat, Dec 27, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Why has it been such a difficult environment for currency traders ?

Friday, October 11, 2013

amb
Benedicte Gravrand, Opalesque Geneva:

Thomas Suter is CEO of Quaesta Capital AG, which manages in excess of $2.5bn in investment products and currency risk management mandates. He has more than 20 years of experience in financial markets and has been with Quaesta since its 2005 start. He recently spoke to Sona Blessing on Opalesque Radio about investing in currency strategies in the current environment.

The FX (foreign exchange) market, in which currencies are traded, is the largest financial market in the world, with currently around $5tln being traded daily.

Over the last five years, following the financial crisis, foreign exchange as an asset class has not done so well, Suter says. 2008 was a great year for FX and there was much enthusiasm around this asset class due to is liquidity, transparency and diversification (due to low correlation) benefits. Several banks, specifically Citibank and Morgan Stanley, started promoting new platforms supporting FX managers.

But the 2008 momentum faded away. There has not been much action among the major currency pairs, and low volatility. "Combine that with booming equity and fixed income markets and this has not been helpful for a topping of currencies as an investment opportunity," Suter notes.

According to the Bank for International Settlements (BIS), currency trading kept increasing in the first year of the financial c......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its